Date:22 December, 2018

New meeting to discuss molecular therapies for liver disease in alpha-1 antitrypsin deficiency

22nd December 2018

A new meeting for clinicians and science researchers has been announced in September 2019. The idea is to discuss therapy of the liver disease in α1-antitrypsin deficiency (AATD). The conference will provide a comprehensive overview and detailed lectures on cutting-edge translational and clinical research and will foster the exchange of ideas among AATD investigators.